Thyroid surgery in 103 children in a single institution from 2000-2014

Osama Ibrahim Almosallam1, Ali Aseeri2, Ahmed Alhumaid1

  • 1From the Department of Surgery, College of Medicine, Qassim University, Buraidah, Al Qassim, Saudi Arabia.

Insights

Thyroid cancer is the most common reason for pediatric thyroid surgery. Fine needle aspiration (FNA) is accurate, but complications like hypocalcemia and nerve injury occur, with a 15% recurrence rate in thyroid cancer.

Area of Science:

  • Pediatric Surgery
  • Endocrinology
  • Oncology

Background:

  • Data on pediatric thyroid surgery outcomes are limited.
  • Thyroid surgery in children presents unique challenges and considerations.
  • Understanding outcomes is crucial for improving pediatric surgical care.

Purpose of the Study:

  • To analyze outcome data for pediatric patients undergoing thyroid surgery.
  • To identify common indications, pathologies, and complications.
  • To assess recurrence rates in pediatric thyroid cancer patients.

Main Methods:

  • Retrospective medical record review of 103 pediatric patients (≤18 years) undergoing thyroid surgery from 2000-2014.
  • Data collected included demographics, clinical details, indications, pathology, complications, and follow-up.
  • Analysis of fine needle aspiration (FNA) diagnostic accuracy and outcomes of radioactive iodine treatment.

Main Results:

  • Malignancy was the most common indication (64%), primarily papillary thyroid cancer.
  • Fine needle aspiration (FNA) showed 94% correlation with final histopathology.
  • Complications included hypocalcemia (22%) and recurrent laryngeal nerve injury (5.8%), with permanent issues in some cases.
  • Recurrence rate for thyroid cancer was 15% after radioactive iodine treatment.

Conclusions:

  • Malignancy is the primary indication for pediatric thyroid surgery.
  • Fine needle aspiration (FNA) is a highly accurate diagnostic tool.
  • Hypocalcemia and recurrent laryngeal nerve injury are significant potential complications.
  • A 15% recurrence rate highlights the need for vigilant follow-up in pediatric thyroid cancer.
Abstract